This site contains promotional content intended for UK Healthcare Professionals and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below.
Kerendia®▼ (finerenone) Primary Care Resources
A non-steroidal mineralocorticoid receptor antagonist for the treatment of CKD (stages 3 & 4 with albuminuria) associated with T2D.
Explore the link between chronic kidney disease and cardiovascular disease, highlighting the importance of early assessment and treatment for optimal patient outcomes.
A practical guide on identification of diabetic kidney disease in primary care, including:
- UACR testing for early detection
- Management strategies including pharmacotherapy
Help your patients at risk of end-stage renal disease.
A patient counselling aid for healthcare professionals.
RP-KER-GB-1106 | January 2025
- Footnotesexpand_less
- aCKD; chronic kidney disease
- bT2D; type 2 diabetes